Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-88
SponsorUniversity of Maryland, Baltimore
About this trial
This project examines, in chronic pain, the mechanisms of immersive virtual reality compared to the mechanisms of placebo hypoalgesia. The potential of developing new non-pharmacological premises for low-risk interventions for pain management is high.
Eligibility criteria
Qualifiers
Age (18-88 years)
English speaker (written and spoken)
Temporal Mandibular Disorder (TMD) for at least 3 months
TMD Grade Chronic Pain Scale (GCPS) ≥ 0
Disqualifiers
Present or past degenerative neuromuscular disease
Cardiovascular, neurological diseases, pulmonary abnormalities, kidney disease, liver disease, history of cancer within past 3 years
Cervical pain (e.g. stenosis, radiculopathy)
Any personal (or family first degree) history of mania, schizophrenia, or other psychoses
Trial design
Treatments tested in this trial
- RelieVRx
- Sham-VR
- No-VR (natural history control)
Treatment groups
78 Participants
are divided into 2 treatment groupsLocations
2Luana Colloca21201-1512, BaltimoreMaryland, United States
University of Maryland21201-1512, BaltimoreMaryland, United States
Sponsors and collaborators
University of Maryland, Baltimore
Lead sponsor
Source ClinicalTrials.gov